title: [Ovarian hyperstimulation syndrome. Notes on the physiopathology and treatment apropos of 3 cases].
abstract: Hyperstimulation appeared in one case on the 10th 11th day after ovulation, allowing by its presence the very precocious diagnosis of successful fecondation. The study of blood coagulation revealed that hypercoagulability was mainly related to hyperactivity of the thrombocytes and of the coagulation proteins. The pathogenesis of the syndrome is discussed. Increase in the permeability of the capillary vessels and hypovolemia seem to be responsible for the main accidents. Unfortunately as we have no real mean of decreasing the permeability of the capillary vessels, the treatment can be directed only against hypovolemia and its results. The infusion of macromolecular fluids, the restriction of sodium and water intake, together with the prescription of spironolactone have been successfully employed in those three cases.
mesh_terms: D000328:Adult; D001201:Ascites / Q000209:etiology; D002199:Capillary Permeability; D006063:Chorionic Gonadotropin / Q000009:adverse effects; D005260:Female; D006065:Gonadotropins, Pituitary / Q000009:adverse effects; D006801:Humans; D006876:Hydrothorax / Q000209:etiology; D006984:Hypertrophy; D009325:Nausea / Q000209:etiology; D010049:Ovarian Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D010952:Plasma Substitutes / Q000627:therapeutic use; D011247:Pregnancy; D011276:Pregnanediol / Q000032:analysis; D011279:Pregnanetriol / Q000032:analysis; D012709:Serum Albumin / Q000627:therapeutic use; D012769:Shock / Q000209:etiology; D013148:Spironolactone / Q000627:therapeutic use; D013577:Syndrome
chemical_list: D006063:Chorionic Gonadotropin; D006065:Gonadotropins, Pituitary; D010952:Plasma Substitutes; D012709:Serum Albumin; D011279:Pregnanetriol; D013148:Spironolactone; D011276:Pregnanediol
vernacular_title: Syndrome d'hyperstimulation ovarienne commentaires sur la physiopathologie et le traitement, à propos de 3 observations